Patients With Folate Receptor Alpha Positive Recurrent Platinum Sensitive Epithelial Ovarian News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Patients with folate receptor alpha positive recurrent platinum sensitive epithelial ovarian. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Patients With Folate Receptor Alpha Positive Recurrent Platinum Sensitive Epithelial Ovarian Today - Breaking & Trending Today

Maintenance Mirvetuximab Soravtansine Plus Bevacizumab Under Exploration in FRα+ Ovarian Cancer

The efficacy of maintenance mirvetuximab soravtansine plus bevacizumab is being compared with bevacizumab alone in patients with folate receptor alpha–positive recurrent platinum-sensitive epithelial ovarian, fallopian tube, or peritoneal cancers that did not progress on second-line triplet therapy in the phase 3 GLORIOSA study. ....

Sri Lanka , Immunogen Incyte , Iovance Biotherapeutics , Vincerx Pharma , Abbvie Stemcentrx , Genentech Roche , Bristol Myers Squibb , Sutro Biopharma , Acerta Pharma , Umoja Biopharma , Sumitomo Dainippon Pharma Oncology Inc , Ludwig Institute For Cancer Research , Janssen Research Development , Toray Industries , Jazz Pharmaceuticals , Arcus Biosciences , Atossa Therapeutics , Clovis Oncology , Corcept Therapeutics , Elevar Therapeutics , Laekna Therapeutics , Onconova Therapeutics , Array Biopharma , Cerulean Pharma , Janssen Research , Karyopharm Therapeutics ,